Migraine is very common-more common than diabetes and asthma combined. It affects almost 20% of women and 10% of men, and will make up a large number of people visiting a neuro-ophthalmology clinic. The World Health Organization has listed migraine in the top 10 most disabling conditions. Keeping up with advances in migraine pathophysiology and treatment is almost a full-time job, but every neuro-ophthalmologist must know about these new advances in treatment since individuals will be requesting medication or presenting with migraine in the neuro-ophthalmology clinic.
Date
2019-03
Language
eng
Format
video/mp4
Relation is Part of
NANOS Annual Meeting 2019: New Information I Should Know
Publisher
Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
